CTI BioPharma Announces FDA Accelerated Approval of VONJO (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia'

Press/Media

Period28 Feb 2022

Media coverage

1

Media coverage

  • TitleCTI BioPharma Announces FDA Accelerated Approval of VONJO (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia'
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date28/02/22
    PersonsJohn Mascarenhas
View all 1
View less